Related Experiment Video

Updated: Jul 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice

C-M Liu1, Z Yang, C-W Liu

  • 1Molecular Virology Research Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Cancer Gene Therapy
|September 22, 2007
PubMed

Insights

Targeting Foxo-1 (forkhead box protein 1) with RNA oligonucleotides increases skeletal muscle mass by upregulating MyoD and suppressing myostatin. This suggests Foxo-1 is a key factor in muscle atrophy and a potential therapeutic target.

Area of Science:

  • Molecular biology
  • Cell biology
  • Physiology

Background:

  • Foxo-1 (forkhead box protein 1) is upregulated in skeletal muscle during energy-deprived states like fasting, cancer, and diabetes.
  • Muscle atrophy, or wasting, is a significant concern in various catabolic conditions.

Purpose of the Study:

  • To investigate the role of Foxo-1 in muscle atrophy.
  • To evaluate the therapeutic potential of targeting Foxo-1 mRNA for muscle wasting conditions.

Main Methods:

  • Utilized a Foxo-1 specific RNA oligonucleotide to target Foxo-1 mRNA in C2C12 mouse skeletal myoblast cells.
  • Administered the RNA oligonucleotide in vivo to normal and cancer cachexia mouse models.
  • Assessed changes in Foxo-1 expression, skeletal muscle mass, MyoD, and GDF-8 (myostatin) levels.

Main Results:

  • The RNA oligonucleotide successfully reduced Foxo-1 expression in both cell cultures and mouse models.
  • Targeting Foxo-1 led to a significant increase in skeletal muscle mass in normal and cachectic mice.
  • Blocking Foxo-1 expression upregulated the myogenic factor MyoD and suppressed the muscle negative regulator GDF-8 (myostatin).

Conclusions:

  • Foxo-1 plays a critical role in the development of muscle atrophy.
  • Targeting Foxo-1 represents a promising molecular strategy for treating muscle wasting conditions.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...